Abstract
CheckMate 77 T: A phase 3 trial of neoadjuvant nivolumab (NIVO) + chemotherapy (chemo) followed by adjuvant NIVO in resectable early-stage non-small cell lung cancer (NSCLC)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have